Media Engagement
- Yahoo News, 8/24/2023, CVS launches unit to market and co-produce biosimilar medicines, https://cutt.ly/7wjxaZIB
- First Word, 7/30/2023, The ICER Effect: Payer Perspectives, https://cutt.ly/pwpoIJk5
- Reuters, 7/10/2023, Cigna to add three Humira biosimilars to drug reimbursement list, https://cutt.ly/twi0bewm
- Reuters, 6/30/2023, Analysis: New Humira rivals likely to hit US market with small discounts in July, https://cutt.ly/5wu0yqpE
- Rheumatologist, 4/7/2023, Mark Cuban: Mixing Up the Pharmaceutical Landscape, https://cutt.ly/D74VIWw
- Morning Brew, 4/4/2023, Drugs left off PBM lists can lead to worse patient outcomes, higher costs, https://cutt.ly/k7cwqIX
- Health Central, 4/3/2023, Asthma Meds, Insurers, and the Practice of Non-Medical Drug Switching, https://cutt.ly/Y7aRBIk
- Employee Benefit News, 4/3/2023, The insulin cap is great news for patients — but employers may see even higher premiums, https://cutt.ly/x7aRD9l
- Medscape, 3/30/2023, Biosimilars and Patients: Discussions Should Address Safety, Cost, and Anxiety About Change, https://cutt.ly/awwDh5aY
- Pharmacy Practice News, 3/15/2023, New Report: Pharmacists Providing Vax More Often Than MDs, https://cutt.ly/34yvIC0
- Docwire, 3/10/2023, Report Shows Increase in Pharmacy-Based Vaccinations in U.S. Across Multiple Vaccines, https://cutt.ly/n4jdotb
- Managed Healthcare Executive, 3/8/2023, The List of PBM Formulary Exclusions Got Longer in 2023, https://cutt.ly/r4js4eP
- Pluribus News, 2/15/2023, As Covid emergency expires, states want to let pharmacists give vaccines, https://cutt.ly/f3JcMj9
- Creaky Joints, 2/15/2023, More Biosimilars Are Coming, But Don’t Expect Instant Savings, https://cutt.ly/N3DQL4N
- Employee Benefits News, 2/9/2023, The end of the PREP Act will impact access to vaccinations, https://cutt.ly/z3kpr71
- Reuters,1/31/2023, AbbVie's Humira gets a U.S. rival, but costs could stay high, https://cutt.ly/Q9G10zY
- Drug Channels, 1/10/2023, The Big Three PBMs’ 2023 Formulary Exclusions: Observations on Insulin, Humira, and Biosimilars, https://cutt.ly/b4gIlQN
- Inside Health Policy, 12/13/2022, CMS Rejects Call to Ban Copay Accumulators In Draft 2024 Exchange Rule, https://cutt.ly/h2N3o7d
- USA Today, 11/3/2022, Is prescription copay assistance contributing to rising drug prices? Why buyers should beware. https://cutt.ly/X2N3ttj
- USA Today, 11/1/2022, How do patient assistance programs work? The pros and cons of prescription coupons and more. https://cutt.ly/t2N3qHM
- Creaky Joints, 8/31/2022, Tuberculosis Vaccine Might Offer Some Protection Against COVID, https://cutt.ly/K2N97YI
- Creaky Joints, 8/8/2022, Are Pharmacists the Key to Increased Vaccination Rates? https://cutt.ly/w2N99Av
- Contagion Live, 8/4/2022, In Low-Income Communities, Pharmacists Can Play a Critical Role in Vaccine Access, https://cutt.ly/L2N9N3s
- Healio, 7/20/2022, Nearly half of formulary exclusions offer ’questionable‘ clinical, economic benefit, https://cutt.ly/F2N9ZtO
- Creaky Joints, 7/8/2022, Warning: Your Health Insurance Might Not Cover the Meds You Need Most, https://cutt.ly/42N9Hgp
- Pharmacy Today, 7/7/2022, Pharmacists’ expanded scope of practice here to stay?
- American Journal of Managed Care, 6/28/2022, Mental Health, Immunizations, Sleep Focus of Barriers in Prevention and High-Value Care, https://cutt.ly/Y2N9Pp5
- Infectious Disease Advisor, 5/27/2022, The Case for Expanding Pharmacists’ Authority to Administer Vaccines, https://cutt.ly/c2N9U91
- Pharmacy Today, 3/1/2022, Most physicians unable to estimate patients’ out-of-pocket costs: How pharmacists can help
- The Center for Biosimilars, 1/12/2022, Biosimilar Progress and Education in the United States, https://cutt.ly/XIpqoxL
- accessWDUN.com, 12/31/2021, Covid-19 vaccines and antiviral treatments, https://cutt.ly/w2N9R8b
- Pharmacy Today, 10/01/2021, Walmart–Novo Nordisk insulin offers deep discounts to select few
- Ohio Capital Journal, 7/22/2021, Chucking insurance, https://cutt.ly/f2N9Q94
- Pharmacy Today, 5/12/2021, Cash-based pharmacies deliver transparency, savings
- Biosimilars Review and Report, 4/6/2021, Biosimilars, Employers, Medicaid, and Rebates, https://cutt.ly/y2N9kzv
- The Hill, 3/6/2019, Drug rebates not benefiting sicker patients, https://cutt.ly/U2N9aeW
- Politico, 5/9/2018, A Better Prescription: Biosimilars and a Pathway to Patient Choice, https://cutt.ly/Z2N2MXZ
- Managed Healthcare Executive, 1/28/2018, Pfizer VP Robert Popovian Talks Value-Based Reimbursement, https://cutt.ly/l2N24pD
- Public Affairs Council, 11/13/2017, Do Big Donors Compromise Think Tanks? https://cutt.ly/M2N2Xso
- Pink Sheet, 8/27/2014, Biomedical Reform Legislation May Be Piecemeal But Holistic, https://cutt.ly/v2N2K7V
- Bloomberg News, 3/4/2011, Pfizer-Backed Bills Threaten Medicaid Generic Savings: Insight
- Pink Sheet, 2/21/2011, Lobbying Around State eRx Legislation Pits Payers Against Manufacturers
- The Grand Rapids Press, 3/9/2008, Health plans push harder for use of generic drugs, not as 'equivalents' but as 'alternatives', https://cutt.ly/E2N2bSK
- USA Today, 12/9/2004,,Web site compares drugs for 'best buys', https://cutt.ly/w2N2xV9
- Los Angeles Times, 9/10/1995, Drug Use Weakened Allegations of Abuse, https://cutt.ly/B2N2zkA